l-carnitine tablet formulation EP0354848A1 - Pharmaceutical and/or dietetical compositions containing L- carnitine and L-lysine One Factor at a Time

10.3389/fnsyn.2017.00015 53

NDC 63323-170-05 17005PX SODIUM PHOSPHATES INJECTION, USP Phosphorus 15 mmol / 5 mL (3 mmol/mL) Sodium 20 mEq / 5mL (4 mEq/mL) MUST BE DILUTED PRIOR TO IV USE 5 mL Single Dose Vial NDC 63323-170-05 17005PX SODIUM PHOSPHATES INJECTION, USP Phosphorus 15 mmol / 5 mL (3 mmol/mL) Sodium 20 mEq / 5mL (4 mEq/mL) MUST BE DILUTED PRIOR TO IV USE 25 x 5 mL Single Dose Vials

Most patients begin with modest doses and gradually increase them under clinical supervision until they receive the most effective pain relief with the fewest adverse effects

[DOI] [PubMed] [Google Scholar] 581.Shen Z., Xu L., Wu T., Wang H., Wang Q., Ge X., Kong F., Huang G., Pan X

Vascular Contributions to Migraine: Time to Revisit